Skip to main content

Overview

I obtained my Ph.D. in Oncological Sciences from University of Utah (Supervisor, Dr. Bradley Cairns, Howard Hughes Medical Institute, Huntsman Cancer Institute). My PhD thesis work resulted in several key discoveries on the fundamental mechanisms of chromatin regulation of gene expression during development. I identified and functionally characterized the Yaf9 component of the SWR1 and NuA4 complexes which are essential for proper regulation of gene expression (Mol. Cell. Biol. (2004) 24, 9424-9436). I also investigated the genome-wide dynamics of Htz1, a histone H2A variant and delineated the molecular mechanism by which Htz1 poises repressed/basal promoters for activation through histone loss (Cell (2005) 123, 219-231). Furthermore, I initiated and helped to develop multiple projects in which we studied how distinctive chromatin in sperm packages genes for embryo development in both human and zebrafish model systems (Nature (2009) 460(7254), 473-8; Genome Res. (2011) 21(4), 578-89). These research experiences endowed me with expertise in genomics/epigenomics and transcriptional regulation.

 

During my postdoctoral fellowship (Supervisor, Dr. Elaine Fuchs, Howard Hughes Medical Institute, the Rockefeller University), I extended my research experience into the mammalian cell biology and developmental biology. My work resulted in the discovery that the Hippo signaling pathway is required for balancing growth and differentiation during epidermal development, and its aberrant regulation result in various types of skin cancers (Proc Natl Acad Sci U S A. 2010. 108, 2270-5).

Highlights

  1. 1
    Journal of extracellular biology · 2024
    PMID: 39045341PMCID: PMC11263976DOISenior author10 citations

Publications

33 publications

Active

5 grants
  • MPI
    Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection
    National Cancer Institute · 2017–2028· 2 renewals
    R01CA218513-06A1
  • Co-I
    Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression
    National Institute of Diabetes and Digestive and Kidney Diseases · 2023–2028
    R01DK137517-04
  • Co-I
    Targeting Ovarian Cancer Metastasis: From Pre-metastatic Niches to Liquid Biopsies
    Pershing Square Foundation · 2025–2028
    PSF 251938-01
  • Co-I
    Pancreatic Cancer Detection Consortium
    National Cancer Institute · 2017–2027 · via University of Nebraska Medical Center· 2 renewals
    U01CA210240-08
  • Co-I
    Targeting the Axis of Tumor-Derived Extracellular Vesicles, Lung Macrophages, and Neutrophil Extracellular Traps to Prevent Pulmonary Metastasis in Osteosarcoma
    Osteosarcoma Institute · 2024–2027
    OI 241832-01
Completed grants (6)
  • Co-I
    Quantitative Analysis of Cancer-associated EVs.
    National Cancer Institute · 2023–2025 · via Cellarcus
    R44CA272098-01A1
  • KP
    Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
    National Institute of Allergy and Infectious Diseases · 2019–2024
    U19AI144301-05
  • Co-I
    Defining Neoantigen Immunodominance for Antigen Selection and Biomarker Discovery in Human Pancreatic Cancer Immunotherapy
    National Cancer Institute · 2017–2022 · via Sloan-Kettering Institute for Cancer Research
    U01CA224175-01
  • KP
    Study Characterizing Cellular, Extracellular Composition and Genetic Profiling of Relapsed/Refractory Pediatric Tumors (POETIC)
    Pediatric Oncology Experimental Therapeutics Investigators' Consortium · 2016–2021 · via Sloan-Kettering Institute for Cancer Research
    No publications yet
    POETIC 184075-03
  • KP
    Circulating Exosomal microRNA as Biomarkers of Medulloblastoma Progression, Metastasis, and Recurrence
    Starr Cancer Consortium · 2016–2018
    I9-A9-056
  • KP
    Organ-Tropic Metastatic Secretomes and Exosomes in Breast Cancer
    U.S. Department of Defense · 2013–2018
    W81XWH-13-1-0427

News mentions

  • T Cells Secrete DNA to Boost the Immune System’s Cancer-Fighting Ability
    April 30, 2026

    Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.

  • Cancers in Distant Organs Alter Liver Function
    May 24, 2023

    Cancers often release molecules into the bloodstream that pathologically alter the liver, shifting it to an inflammatory state, causing fat buildup and impairing its normal detoxifying functions.

  • NIH Grant Funds Research on Autoimmune Diseases in Children
    August 8, 2019

    Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to establish an Autoimmunity Center of Excellence dedicated to understanding the mechanisms that contribute to autoimmune diseases in children.Weill Cornell Medicine has been awarded a prestigious grant from the National Institutes of Health to establish an Autoimmunity Center of Excellence dedicated to understanding the mechanisms that contribute to autoimmune diseases in children.